Advertisement

Picture EBD Group Digital Medicine & Medtech Showcase 2021 at BTS2021 651x81
Document › Details

Huntsworth. (11/6/20). "Press Release: Huntsworth Expands Global Health Network with Nucleus Acquisition". London.

Organisations Organisation Huntsworth plc
  Group Huntsworth (Group)
  Organisation 2 Nucleus Global (GB)
  Group Huntsworth (Group)
Products Product public relations / investor relations / marcom (services)
  Product 2 HEALTH (HUMAN)
Index term Index term Huntsworth–Clayton, Dubilier & Rice: investment, 202003–202005 acquisition 100% of Huntsworth plc for £575m in cash + delisting
Person Person Taaffe, Paul (Huntsworth 201903 CEO)
     


Huntsworth (www.huntsworth.com), an international healthcare and communications group, has announced an agreement to acquire Nucleus Global, one of the world’s largest medical specialist communications groups.

This marks Huntsworth’s second acquisition under the ownership of Clayton, Dubilier & Rice and demonstrates the group’s commitment to strengthening its offerings in the healthcare category. Huntsworth, with the addition of Nucleus Global to the healthcare operating units of Huntsworth, MediStrava, the Evoke Group and The Creative Engagement Group – will provide pharmaceutical and biotechnology companies with the most complete suite of strategic counsel, medical affairs, market access, stakeholder engagement and marketing services across all therapeutic areas and across the entire drug development and commercialization lifecycle of molecule to medicine.

“The addition of Nucleus Global to Huntsworth creates one of the largest high science teams in the world to meet the increasingly complex needs of next generation prescription drug development,” said Paul Taaffe, CEO of Huntsworth. “Together, Nucleus Global, and Huntsworth are one of the most powerful combinations in healthcare communications.”

Nucleus was founded in 1986 and has become one of the largest medical specialist communications networks in the world. Globally, theyhave over 800 experts with 14 offices to help deliver world-class compliant events, publications and digital programmes for the major healthcare and medical brands around the world.

“We are excited to combine our expertise with the breadth of solutions across Huntsworth to deliver even more value to our clients, and our teams, which will help them capitalise on their opportunities to provide patients with the most effective healthcare solutions,” said Stephen Cameron, Chairman of Nucleus Global.

Nucleus Global’s Founder and Chair, Stephen Cameron will join the main Board of Huntsworth and continue to lead NucleusGlobal.


###


About Huntsworth:

Huntsworth is an international healthcare and communications group. The Group's principal areas of focus are marketing, medical and immersive communications services to healthcare clients, which are primarily large and mid-size pharmaceutical and biotech companies. It also has Constellation Communications group, which provides a wide range of communications and advisory services including strategic communications, public affairs, investor relations and consumer marketing.


About Nucleus Global:

Nucleus Global is a medical communications group which provides strategic communications, publications planning, experts and patients engagement, scientific events management, medical education, internal communications, trainings and clinical support for the pharmaceutical and biotechnology companies. Nucleus Global has its headquartersin London and operates dedicated, conflict-free teams across 14 offices with over 800 employees in the US, Europe and Asia-Pacific. The Sellers were advised by Taylor Wessing LLP. For more information, please visit www.nucleus-global.com/.


Contact:
Theresa Liddy Dolge
EVP, Chief Media Relations Officer
(609) 915-2156
Theresa.Dolge@evokegroup.com

   
Record changed: 2020-11-13

Advertisement

Picture [iito] Plain Stupid Simple 650x80px

More documents for Huntsworth (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture EBD Group BioTech Showcase 2021 Whitepaper Presenting 650x80




» top